Michael Fumento
Factual · Powerful · Original · Iconoclastic
Advice & Dissent: 2006
I have repeatedly written that efforts to downplay the importance of adult stem cells often go so far as to even deny their existence, even though they've been curing people since the 1950s, now cure or treat over 70 types of cancer, cure or treat myriad other diseases, and are…Read More
Scripps Howard columnist Paul Campos, best known for his columns and book claiming that obesity is actually good for you, is now "weighing in" on terrorism. The University of Colorado law professor labels it a "microscopic risk." Maybe he's looking through the wrong end of the…Read More
In my Weekly Standard "Fuss and Feathers" piece of 21 November 2005, I ripped the "50% death rate" experts claimed avian flu victims suffered. "First, all avian flu deaths so far have occurred in countries with medical systems that are dismal compared with ours. Would you choose…Read More
It was 13 years ago, writing in Investor's Business Daily, that I became the first reporter in the country to present evidence that cell phones have no link to brain cancer. Now the biggest study ever on the issue has been released and it finds . . . cell phones have no link to…Read More
In his latest "news analysis," Business Week's Eamon Javers concludes, "The money didn't influence his my writing, he adds. His syndicate, Scripps Howard, felt differently. On Jan. 13 it canceled Fumento's weekly column." So now Javers is telling us what went inside the minds of…Read More
In his Jan. 21 column, "Writers' Opinions for Hire," LA Times media critic Tim Rutten makes a claim against me regarding my dismissal from the Scripps Howard News Service that's both libelous and false. The news of my dismissal from Scripps broke in the January 13 Business Week…Read More
Paul Thacker writes in his Jan. 26 article centering on Fox columnist Steve Milloy: "Earlier this month, BusinessWeek Online reported that, in 1999, Scripps Howard columnist Michael Fumento received $60,000 from Monsanto, one of the biotech companies he later covered in his…Read More
I was flacked today by a PR agency declaring in the subject line, "Breast Cancer Doesn't Discriminate" and then stating in the body, "Statistics show that although African American women have a lower rate of breast cancer compared with white counterparts, their mortality rates…Read More
Cathy Seipp has a commentary in Sunday's LA Times of which I don't entirely approve but nonetheless deserves reading, regarding our earlier back and forth in National Review Online and what brought it all about. What I don't care for: First, it's hard to tell to what extent she's…Read More
I asked one, a blogger. "Insofar as you've posted my response to Cathy Seipp's piece in NRO, you know that I received a book grant in 1999 that ran out in 2000 and my column began in 2003. Could you please explain to your readers how that makes me a "columnist for hire." His…Read More
Biography
